| Key Financial Ratios of Aarti Drugs (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
17.18 |
15.35 |
16.50 |
21.04 |
27.65 |
|
| Diluted EPS (Rs.) |
17.18 |
15.35 |
16.50 |
21.04 |
27.65 |
|
| Cash EPS (Rs.) |
22.47 |
20.62 |
21.61 |
26.18 |
32.76 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
137.10 |
127.83 |
120.34 |
104.99 |
92.23 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
137.10 |
127.83 |
120.34 |
104.99 |
92.23 |
|
| Dividend / Share(Rs.) |
1.00 |
1.00 |
1.00 |
1.00 |
2.50 |
|
| Revenue from Operations/Share (Rs.) |
238.16 |
246.58 |
269.76 |
243.11 |
205.46 |
|
| PBDIT/Share (Rs.) |
30.26 |
29.40 |
30.74 |
34.88 |
43.74 |
|
| PBIT/Share (Rs.) |
25.03 |
24.22 |
25.63 |
29.76 |
38.64 |
|
| PBT/Share (Rs.) |
21.78 |
20.94 |
22.12 |
27.59 |
36.24 |
|
| Net Profit/Share (Rs.) |
17.24 |
15.43 |
16.50 |
21.06 |
27.65 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
12.70 |
11.92 |
11.39 |
14.34 |
21.29 |
|
| PBIT Margin (%) |
10.50 |
9.82 |
9.50 |
12.24 |
18.80 |
|
| PBT Margin (%) |
9.14 |
8.49 |
8.19 |
11.34 |
17.63 |
|
| Net Profit Margin (%) |
7.23 |
6.25 |
6.11 |
8.66 |
13.45 |
|
| Return on Networth / Equity (%) |
12.57 |
12.07 |
13.71 |
20.05 |
29.98 |
|
| Return on Capital Employed (%) |
14.57 |
14.97 |
17.39 |
23.35 |
32.29 |
|
| Return on Assets (%) |
6.92 |
6.53 |
6.96 |
9.58 |
15.74 |
|
| Total Debt/Equity (X) |
0.41 |
0.40 |
0.48 |
0.53 |
0.34 |
|
| Asset Turnover Ratio (%) |
0.98 |
1.04 |
1.18 |
1.23 |
1.23 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.67 |
1.73 |
1.62 |
1.49 |
1.84 |
|
| Quick Ratio (X) |
1.10 |
1.08 |
1.05 |
0.92 |
1.09 |
|
| Inventory Turnover Ratio (X) |
5.12 |
3.19 |
3.52 |
3.47 |
3.23 |
|
| Dividend Payout Ratio (NP) (%) |
5.80 |
6.47 |
6.05 |
4.74 |
9.04 |
|
| Dividend Payout Ratio (CP) (%) |
4.44 |
4.85 |
4.62 |
3.82 |
7.63 |
|
| Earnings Retention Ratio (%) |
94.20 |
93.53 |
93.95 |
95.26 |
90.96 |
|
| Cash Earnings Retention Ratio (%) |
95.56 |
95.15 |
95.38 |
96.18 |
92.37 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
3,610.69 |
4,457.63 |
3,658.44 |
4,485.21 |
6,761.47 |
|
| EV/Net Operating Revenue (X) |
1.66 |
1.97 |
1.46 |
1.99 |
3.53 |
|
| EV/EBITDA (X) |
13.07 |
16.49 |
12.85 |
13.89 |
16.58 |
|
| MarketCap/Net Operating Revenue (X) |
1.43 |
1.76 |
1.25 |
1.76 |
3.38 |
|
| Retention Ratios (%) |
94.19 |
93.52 |
93.94 |
95.25 |
90.95 |
|
| Price/BV (X) |
2.48 |
3.39 |
2.81 |
4.09 |
7.53 |
|
| Price/Net Operating Revenue |
1.43 |
1.76 |
1.25 |
1.76 |
3.38 |
|
| Earnings Yield |
0.05 |
0.04 |
0.05 |
0.05 |
0.04 |
|
Source : Dion Global Solutions Limited
